HOME Top Market Reports Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based - Global Forecast to 2021

Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based - Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: July 2016
Report Code: MD 2702

 

  Speak to Analyst Enquiry Before Buying  
purchase report
download pdf  request for customisation


The point-of-care diagnostics market is expected to reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, at a CAGR of 9.8% during the forecast period. Rise in the prevalence of lifestyle and infectious diseases and the increasing inclination towards home healthcare across the globe are key factors fueling the growth of the market across the globe. Private investments and venture funding towards the development of new products along with the growing government support to increase the adoption of POC devices are boosting market growth. However, pricing pressures owing to reimbursement cuts and budget constraints hampering profits of these devices is restraining the growth of this market.

Emerging markets including China, India, and Brazil offer high growth potential for companies engaged in the development and distribution of point-of-care diagnostic devices. Growing initiatives by market players, increasing patient population base, and rising number of partnerships and joint ventures among POC providers are the key factors propelling the growth of point-of-care diagnostics market in the emerging countries.

Abbott Laboratories, Inc. (U.S.),Roche Diagnostics Limited (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), and Nova Biomedical (U.S.) are some of the key players in the market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each product in emerging nations. The report provides qualitative insights about growth rates and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment.

Target Audience:

  • Point-of-care diagnostic manufacturing companies
  • Clinical laboratories
  • Hospitals, clinics, and special areas (such as sports and military)
  • Research institutes and clinical research organizations (CROs)
  • Market research and consulting firms

To know about the assumptions considered for the study, download the pdf brochure

Scope of the Report

This research report categorizes the point-of-care diagnostics market into the following segments:

Global Point-of-care Diagnostics Market, by Product

  • Glucose Monitoring Kits
  • Cardiometabolic Monitoring Kits
    • Cardiac Markers
    • Blood Gas/Electrolytes Testing Kits
    • HbA1c Testing Kits
    • Lipids Testing
  • Infectious Diseases Testing Kits
    • Influenza Testing Kits
    • HIV Testing Kits
    • Hepatitis C Testing Kits
    • Sexually-transmitted Diseases (STDs) Testing Kits
    • Tropical Diseases Testing Kits
    • Healthcare-associated Infections (HAIs)
    • Respiratory Infections Testing Kits
    • Others
  • Coagulation Monitoring Kits
    • Prothrombin Time (PT/INR) Testing Kits
    • Activated Clotting Time (ACT/APTT) Testing Kits
  • Pregnancy and Fertility Testing Kits
    • Pregnancy Testing Kits
    • Fertility Testing Kits
  • Tumor/Cancer Markers
  • Urinalysis Testing Kits
  • Cholesterol Test Strips
  • Hematology Testing Kits
  • Drugs of Abuse Testing Kits
  • Fecal Occult Testing Kits
  • Others

Global Point-of-care Diagnostics Market, by Prescription Mode

  • Prescription-based Testing Kits
  • Over-the-counter (OTC) Testing Kits

Global Point-of-care Diagnostics Market, by End User

  • Professional Diagnostic Centers
    • Hospitals/Critical Care Centers
    • Outpatient Healthcare Settings
    • Ambulatory Care Settings
  • Research Laboratories 
  • Home Care
  • Other End Users

Global Point-of-care Diagnostics Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company‘s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five)

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies in the point-of-care diagnostics market

Table of Contents

1 Introduction (Page No. - 18)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
    1.4 Markets Covered
           1.4.1 Years Considered for the Study
    1.5 Currency
    1.6 Limitations
    1.7 Stakeholders

2 Research Methodology (Page No. - 23)
    2.1 Research Data
           2.1.1 Secondary Data
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Data
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Key Industry Insights
    2.2 Market Size Estimation Methodology
           2.2.1 Bottom-Up Approach
           2.2.2 Top-Down Approach
    2.3 Research Design
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 32)
    3.1 Introduction
    3.2 Current Scenario
    3.3 Future Outlook
    3.4 Conclusion

4 Premium Insights (Page No. - 37)
    4.1 Market Overview
    4.2 Geographic Analysis: Market Growth Rate, By Product (2016–2021)
    4.3 Geographic Analysis: Market Size, By Mode of Prescription, 2016 vs 2021
    4.4 Market, By End User and Region, 2016 (USD Million)

5 Market Overview (Page No. - 41)
    5.1 Introduction
    5.2 Market Segmentation
    5.3 Market Dynamics
           5.3.1 Drivers
                    5.3.1.1 High Prevalence of Infectious Diseases in Developing Countries
                    5.3.1.2 Increasing Incidence of Lifestyle Diseases
                    5.3.1.3 Rising Usage of Home-Based POC Devices
                    5.3.1.4 Growing Government Support
                    5.3.1.5 Private Investments and Venture Capital Activities
                    5.3.1.6 Technological Advancements and New Product Launches
                    5.3.1.7 Growing Number of Regulatory Approvals for Novel Immunoassay Techniques
                    5.3.1.8 Shortage of Skilled Laboratory Technicians Increasing Preference of POC Testing
                    5.3.1.9 Rising Number of Clia-Waived POC Tests
           5.3.2 Restraints
                    5.3.2.1 Product Recalls
                    5.3.2.2 Pricing Pressures Owing to Reimbursement Cuts and Budget Constraints Hampering Profits
                    5.3.2.3 Stringent and Time-Consuming Regulatory Policies are Significantly Increasing Gestation Period for Product Launches
           5.3.3 Opportunities
                    5.3.3.1 Emerging Markets (India, China, and Brazil) to Pave New Growth Avenues
                    5.3.3.2 Healthcare Decentralization—Converting Lab Tests to POC Tests
                    5.3.3.3 Increasing Number of Conferences and Events
                    5.3.3.4 Miniaturization of POC Testing Devices
                    5.3.3.5 POC Tests With Multiplexing Capabilities
           5.3.4 Challenges
                    5.3.4.1 Lack of Alignment With Definitive Central Lab Methods
                    5.3.4.2 Disadvantages of POC Testing Over Central Lab Methods
                    5.3.4.3 Inadequate Knowledge About Use of POC Devices in Professional Settings
                    5.3.4.4 Reluctance Towards Changing Existing Treatment Practices
           5.3.5 Burning Issues
                    5.3.5.1 Unfavorable Reimbursement Limiting the Adoption of POC Tests
                    5.3.5.2 High Cost of Devices—A Prime Concern
                    5.3.5.3 Negative Public Perception Related to POC Tests

6 Industry Trends (Page No. - 58)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Standardization of POC Testing Devices
           6.2.2 Acquisition of Small Players
           6.2.3 Growing Focus on Microfluidics-Based POC Devices
                    6.2.3.1 Microfluidics-Based Loc Devices Will Bring Laboratory Testing to the Patient’s Fingertips
                    6.2.3.2 Evolution of Paper-Based Microfluidic POC Diagnostic Devices
    6.3 Pricing and Cost Analysis
    6.4 Porter’s Five Forces Analysis
           6.4.1 Threat From New Entrants
           6.4.2 Threat of Substitutes
           6.4.3 Bargaining Power of Suppliers
           6.4.4 Bargaining Power of Buyers
           6.4.5 Intensity of Competitive Rivalry
    6.5 Strategic Benchmarking
           6.5.1 Technology Integration & New Product Launches
           6.5.2 Incorporation of Wireless Technology in POC Devices

7 Point-Of-Care Diagnostics Market, By Product (Page No. - 68)
    7.1 Introduction
    7.2 Glucose Monitoring Kits
    7.3 Cardiometabolic Monitoring Kits
           7.3.1 Cardiac Markers
           7.3.2 Blood Gas/Electrolytes Testing Kits
           7.3.3 HBA1C Testing Kits
           7.3.4 LIPID Testing Kits
    7.4 Infectious Disease Testing Kits
           7.4.1 Influenza Testing Kits
           7.4.2 HIV Testing Kits
           7.4.3 Hepatitis C Testing Kits
           7.4.4 Sexually Transmitted Diseases (STDs) Testing Kits
           7.4.5 Tropical Diseases Testing Kits
           7.4.6 Healthcare-Associated Infection Testing Kits
           7.4.7 Respiratory Infections Testing Kits
           7.4.8 Other Infectious Disease Testing Kits
    7.5 Coagulation Monitoring Kits
           7.5.1 PT/INR Testing Kits
           7.5.2 Activated Clotting Time (ACT/APTT) Testing Kits
    7.6 Pregnancy and Fertility Testing Kits
           7.6.1 Pregnancy Testing Kits
           7.6.2 Fertility Testing Kits
    7.7 Tumor/Cancer Markers
    7.8 Urinalysis Testing Kits
    7.9 Cholesterol Test Strips
    7.10 Hematology Testing Kits
    7.11 Drugs-Of-Abuse Testing Kits
    7.12 Fecal Occult Testing Kits
    7.13 Other POC Testing Kits

8 Point-Of-Care Diagnostics Market, By Prescription Mode (Page No. - 109)
    8.1 Introduction
    8.2 Prescription-Based Testing Kits
    8.3 OTC Testing Kits Market

9 Point-Of-Care Diagnostics Market, By End User (Page No. - 115)
    9.1 Introduction
    9.2 Professional Diagnostic Centers
           9.2.1 Hospitals/Critical Care Settings
           9.2.2 Outpatient Healthcare Settings
           9.2.3 Ambulatory Care Settings
    9.3 Research Laboratories
    9.4 Home Care
    9.5 Others

10 Point-Of-Care Diagnostics Market, By Region (Page No. - 124)
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
                        10.2.1.1 Growing Prevalence of Lifestyle Diseases and Rising Geriatric Population
                        10.2.1.2 Increasing Government and Venture Capital Funding
                        10.2.1.3 Growing Number of Product Approvals Using Clia Waiver
                        10.2.1.4 Nih Support for the Development of POC Testing Devices
                        10.2.1.5 Slow Inflow of Multi-Analyte POC Devices
             10.2.2 Canada
                        10.2.2.1 Expanding Patient Population Base
                        10.2.2.2 Increasing Focus of Players on the Canadian Market
                        10.2.2.3 Increasing Government Initiatives
                        10.2.2.4 Lack of Reimbursement and Awareness
     10.3 Europe
             10.3.1 Germany
                        10.3.1.1 Increasing Number of Conferences
                        10.3.1.2 Ongoing Development of Novel Products
                        10.3.1.3 Rising Incidence of Diabetes and Cancer in Germany
                        10.3.1.4 Low Reimbursement Affecting Market Growth in the Country
             10.3.2 France
                        10.3.2.1 Increasing Reimbursement for Point-Of-Care Tests
                        10.3.2.2 High Prevalence of Diabetes in France
             10.3.3 U.K.
                        10.3.3.1 Growing Number of New Product Launches
                        10.3.3.2 Increasing Government Support for POCt Devices
                        10.3.3.3 Budget Constraints Hampering Market Growth
             10.3.4 Rest of Europe (RoE)
     10.4 Asia-Pacific
             10.4.1 Japan
                        10.4.1.1 Growing Initiatives By Market Players
                        10.4.1.2 Increasing Demand for Rapid Flu Tests in Japan
                        10.4.1.3 Centralized Healthcare Delivery System
             10.4.2 China
                        10.4.2.1 Increasing Partnerships and Joint Ventures Fueling Market Growth
                        10.4.2.2 Increasing Support From Government and Private Companies
                        10.4.2.3 Poor Reimbursement and Time-Consuming Product Registration Procedure
             10.4.3 India
                        10.4.3.1 Increasing Prevalence of Target Diseases
                        10.4.3.2 Growing Government Initiatives
                        10.4.3.3 Conferences
                        10.4.3.4 Lack of Reimbursement and Insurance Coverage Hampering Market Growth
             10.4.4 Rest of Asia-Pacific
     10.5 Rest of the World (RoW) 
             10.5.1 Increasing Patient Population in Africa
             10.5.2 Huge Patient Base for Respiratory Diseases
             10.5.3 Growing Initiatives By Market Players

11 Competitive Landscape (Page No. - 168)
     11.1 Overview
     11.2 Market Share Analysis
     11.3 Competitive Situation and Trends
             11.3.1 New Product Launches,Product Enhancements, and Product Approvals
             11.3.2 Agreements, Partnerships, and Collaborations
             11.3.3 Product Showcase and Product Recall
             11.3.4 Acquisitions
             11.3.5 Other Strategies

12 Company Profiles (Page No. - 175)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
     12.1 Introduction
     12.2 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
     12.3 Abbott Laboratories, Inc.
     12.4 Siemens AG
     12.5 Alere Inc.
     12.6 Johnson & Johnson
     12.7 Instrumentation Laboratory (A Werfen Company)
     12.8 Nova Biomedical
     12.9 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
     12.10 Becton, Dickinson and Company
     12.11 PTs Diagnostics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 207)
     13.1 Discussion Guide
     13.2 Other Developments
     13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     13.4 Introducing RT: Real-Time Market Intelligence
     13.5 Available Customizations
     13.6 Related Reports


List of Tables (94 Tables)

Table 1 Point-Of-Care Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 2 Point-of-Care Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 3 Glucose Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 4 Cardiometabolic Monitoring Kits Market Size, By Type, 2014–2021 (USD Million)
Table 5 Cardiometabolic Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 6 Cardiac Markers Market Size, By Region, 2014–2021 (USD Million)
Table 7 Blood Gas/Electrolytes Market Size, By Region, 2014–2021 (USD Million)
Table 8 HBA1C Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 9 LIPID Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 10 Infectious Disease Testing Kits Market Size, By Type, 2014–2021 (USD Million)
Table 11 Infectious Disease Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 12 Influenza Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 13 HIV Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 14 Hepatitis C Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 15 STD Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 16 Tropical Diseases Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 17 Healthcare-Associated Infection Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 18 Respiratory Infections Testing Kits Market Size, By Region, 2014–-2021 (USD Million)
Table 19 Other Infectious Disease Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 20 Coagulation Monitoring Kits Market Size, By Type, 2014–2021 (USD Million)
Table 21 Coagulation Monitoring Kits Market Size, By Region, 2014–2021 (USD Million)
Table 22 PT/INR Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 23 ACT/APTT Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 24 Pregnancy and Fertility Testing Kits Market Size, By Type, 2014–2021 (USD Million)
Table 25 Pregnancy and Fertility Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 26 Pregnancy Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 27 Fertility Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 28 Tumor/Cancer Markers Market Size, By Region, 2014–2021 (USD Million)
Table 29 Urinalysis Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 30 Cholesterol Test Strips Market Size, By Region, 2014–2021 (USD Million)
Table 31 Hematology Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 32 Drugs-Of-Abuse Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 33 Fecal Occult Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 34 Other POC Testing Kits Market Size, By Region, 2014–2021 (USD Million)
Table 35 Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 36 Prescription-Based Testing Kits Market Size, By Region, 2014-2021 (USD Million)
Table 37 OTC Testing Kits Market Size, By Region, 2014-2021 (USD Million)
Table 38 Market Size, By End User, 2014-2021 (USD Million)
Table 39 Professional Diagnostic Centers Market Size, By Type, 2014-2021 (USD Million)
Table 40 Professional Diagnostic Centers Market Size, By Region, 2014-2021 (USD Million)
Table 41 Research Laboratories Market Size, By Region, 2014-2021 (USD Million)
Table 42 Home Care Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 43 Other End Users Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 44 Point-of-Care Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 45 North America: Point-of-Care Diagnostics Market Size, By Country, 2014-2021 (USD Million)
Table 46 North America: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 47 North America: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 48 North America: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 49 U.S.: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 50 U.S.: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 51 U.S.: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 52 Canada: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 53 Canada: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 54 Canada: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 55 Europe: Point-of-Care Diagnostics Market Size, By Country, 2014-2021 (USD Million)
Table 56 Europe: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 57 Europe: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 58 Europe: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 59 Germany: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 60 Germany: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 61 Germany: Point-of-Care Diagnostics Market Size, By End User, 2014-2021 (USD Million)
Table 62 France: Point-of-Care Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 63 France: Point-of-Care Diagnostics Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 64 France: Market Size, By End User, 2014-2021 (USD Million)
Table 65 U.K.: Market Size, By Product, 2014-2021 (USD Million)
Table 66 U.K.: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 67 U.K.: Market Size, By End User, 2014-2021 (USD Million)
Table 68 RoE: Market Size, By Product, 2014-2021 (USD Million)
Table 69 RoE: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 70 RoE: Market Size, By End User, 2014-2021 (USD Million)
Table 71 APAC: Market Size, By Country, 2014-2021 (USD Million)
Table 72 APAC: Market Size, By Product, 2014-2021 (USD Million)
Table 73 APAC: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 74 APAC: Market Size, By End User, 2014-2021 (USD Million)
Table 75 Japan: Market Size, By Product, 2014-2021 (USD Million)
Table 76 Japan: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 77 Japan: Market Size, By End User, 2014-2021 (USD Million)
Table 78 China: Market Size, By Product, 2014-2021 (USD Million)
Table 79 China: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 80 China: Market Size, By End User, 2014-2021 (USD Million)
Table 81 India: Market Size, By Product, 2014-2021 (USD Million)
Table 82 India: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 83 India: Market Size, By End User, 2014-2021 (USD Million)
Table 84 RoAPAC: Market Size, By Product, 2014-2021 (USD Million)
Table 85 RoAPAC: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 86 RoAPAC: Market Size, By End User, 2014-2021 (USD Million)
Table 87 RoW: Market Size, By Product, 2014-2021 (USD Million)
Table 88 RoW: Market Size, By Prescription Mode, 2014-2021 (USD Million)
Table 89 RoW: Market Size, By End User, 2014-2021 (USD Million)
Table 90 Top 5 New Product Launches, Product Enhancements, and Product Approvals, 2015 & 2016
Table 91 Top 5 Agreements, Partnerships, and Collaborations, 2015 & 2016
Table 92 Product Showcase and Product Recall, 2013 & 2014
Table 93 Acquisitions, 2013 & 2014
Table 94 Top 5 Other Strategies, 2013–2015


List of Figures (55 Figures)

Figure 1 Global Point-Of-Care Diagnostics Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Global Market, By Product, 2016 (USD Million)
Figure 5 Global Market, By Product, 2016 vs 2021
Figure 6 Global Market, By Prescription Mode, 2016 vs 2021
Figure 7 Global Market, By Region, 2016-2021 (USD Million)
Figure 8 Increasing Prevalence of Infectious and Lifestyle Diseases is Driving Growth in the Market
Figure 9 The Infectious Disease Testing Kits Segment in the Asia-Pacific Region to Offer Lucrative Growth Opportunities for Market Players
Figure 10 Prescription-Based Testing Kits Segment to Dominate the Market in 2016
Figure 11 Professional Diagnostic Centers to Dominate the Global Market in 2016
Figure 12 POC Diagnostics Market Segmentation
Figure 13 POC Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 14 Global Number HIV Patients, 2014 (Million)
Figure 15 Incidence Rate of TB in Developing Nations, 2014
Figure 16 Estimated Number of Diabetic Patients, By Region, 2015 vs 2040
Figure 17 Healthcare Decentralization Across Prominent Countries, 2013
Figure 18 Pricing Trend (2013-2018): Twofold Decline Expected in the Price of POC Devices in APAC as Compared to North America
Figure 19 Porter’s Five Forces Analysis (2016): Low Capital Requirement Increasing Competition in the Industry
Figure 20 Strategic Benchmarking: Roche and Abbott Largely Focus on Technological Integration and Product Enhancement
Figure 21 Strategic Benchmarking: Alere and Abbott Largely Adopt Strategies for Product Enhancement
Figure 22 The Infectious Disease Testing Kits Segment is Projected to Grow at the Highest CAGR During the Forecast Period
Figure 23 North America is Expected to Dominate the Global Point-Of-Care Diagnostics Market in 2016
Figure 24 North America is Expected to Dominate the Global Glucose Monitoring Kits Market in 2016
Figure 25 The Blood Gas/Electrolytes Segment to Witness Highest Growth in the Global Cardiometabolic Monitoring Kits Market During the Forecast Period
Figure 26 Asia-Pacific to Witness Highest Growth in the Global Cardiometabolic Monitoring Kits Market During the Forecast Period
Figure 27 North America is Expected to Dominate the Global Blood Gas/Electrolytes Market in 2016
Figure 28 Hepatitis C Testing Kits Segment to Witness Highest Growth in the Global Infectious Disease Testing Kits Market During the Forecast Period
Figure 29 North America is Expected to Dominate the Global Infectious Diseases Testing Kits Market in 2016
Figure 30 Asia-Pacific to Witness Highest Growth in the Global Hepatitis C Testing Kits Market in 2016
Figure 31 Asia-Pacific to Witness Highest Growth in the Global Hai Testing Kits Market in 2016
Figure 32 North America is Expected to Dominate the Global Pregnancy & Fertility Testing Kits Market in 2016
Figure 33 North America is Expected to Dominate the Global Hematology Testing Kits Market in 2016
Figure 34 Asia-Pacific to Witness Highest Growth in the Global Fecal Occult Testing Kits Market During the Forecast Period
Figure 35 OTC Testing Kits Segment to Witness Highest Growth During the Forecast Period
Figure 36 North America to Dominate the Prescription-Based Testing Kits Market in 2016
Figure 37 Asia-Pacific to Witness Highest Growth in the OTC Testing Kits Segment
Figure 38 Broad End-User Base for Point-Of-Care Testing Kits
Figure 39 Home Care End-User Segment to Witness Highest Growth During the Forecast Period
Figure 40 North America to Dominate the Professional Diagnostic Centers Market in 2016
Figure 41 Asia-Pacific to Witness Highest Growth During the Forecast Period
Figure 42 Point-Of-Care Diagnostics Market: Growth Forecast, By Region (2016–2021)
Figure 43 North America: Point-Of-Care Diagnostics Market Snapshot
Figure 44 Europe: Point-Of-Care Diagnostics Market Snapshot
Figure 45 APAC: Point-Of-Care Diagnostics Market Snapshot
Figure 46 Global Point-Of-Care Diagnostics Market Share Analysis, By Key Player, 2015
Figure 47 Battle for Market Share: New Product Launches, Product Enhancements, and Product Approvals–Key Growth Strategy Adopted Between 2013 & 2016
Figure 48 Geographic Revenue Snapshot (2015)
Figure 49 Roche Diagnostics Limited: Company Snapshot
Figure 50 Abbott Laboratories, Inc.: Company Snapshot
Figure 51 Siemens AG: Company Snapshot
Figure 52 Alere Inc.: Company Snapshot
Figure 53 Johnson & Johnson: Company Snapshot
Figure 54 Danaher Corporation: Company Snapshot
Figure 55 Becton, Dickinson and Company: Company Snapshot

The global point-of-care (POC) diagnostics market is expected to reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, growing at a CAGR of 9.8% between 2016 and 2021.

On the basis of products, the point-of-care diagnostics market is divided into 12 segments, namely, glucose monitoring kits, infectious diseases testing kits, cardiometabolic monitoring kits, coagulation monitoring kits, hematology testing kits, urinalysis testing kits, cholesterol test strips, drugs-of-abuse testing kits, tumor/cancer markers, pregnancy and fertility testing kits, fecal occult testing kits, and other products. The infectious diseases testing kits segment is expected to grow at the highest CAGR in the next five years, owing to the increasing number of HIV-infected individuals across the globe coupled with increasing availability and awareness about infectious disease POC testing. The glucose monitoring kits segment holds the largest share of the market across the globe. The rising diagnosis of diabetes, ongoing technological advancements in devices used for self-monitoring blood glucose level, and growing patient awareness towards POC testing are the key factors contributing to the growth of this market segment. Moreover, the low cost of test strips and development of novel test strips are other factors contributing to the growth of the glucose monitoring kits market, globally.

On the basis of mode of prescription, the global market is divided into two segments, namely, prescription-based testing kits and over-the-counter testing kits. Prescription-based testing kits segment holds the largest share in the market, owing to rising incidence and prevalence of lifestyle diseases and lack of awareness on over the counter POCT devices.

The global point-of-care diagnostics market is also segmented into three categories on the basis of end users–professional diagnostic centers (hospitals, outpatient healthcare settings, and ambulatory care settings), research laboratories, and home care.

On the basis of geography, this market is classified into four regions, namely, North America (U.S. and Canada), Europe (Germany, France, U.K., and Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and Rest of the World. In 2016, the global point-of-care diagnostics market is estimated to be dominated by North America. A number of factors such as the growing prevalence of lifestyle diseases, increasing number of product approvals, and rising government initiatives for developing novel products in this region are driving the growth of the North American market. The Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors such as growing initiatives by market players to expand their distribution network, increasing patient population base, and rising number of partnerships and joint ventures among POC providers are propelling the growth of the Asia-Pacific market.

Point-Of-Care Diagnostics Market

New product launch is the primary growth strategy adopted by major players to expand their product portfolio in the global point-of-care diagnostics market. Moreover, strategies such as product approvals; partnerships, agreements, and collaborations; and acquisitions were also adopted by a significant number of market players to expand their presence and increase their visibility in the market.

Abbott Laboratories, Inc. (U.S.),Roche Diagnostics Limited (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), and Nova Biomedical (U.S.) are some of the key players operating in the global point-of-care diagnostics market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Available Customizations Title

Client Consult Problem Statement : MnM’s client was interested in assessing global diagnostic blood gas analyzers market analysis and wanted a deep-dive analysis and estimation of the market size and market volume on the basis of brands offered by the key players in the market Client was also interested in the market share of major players and their forecast on the basis of brand sales and the major factors influencing the growth of the market (drivers, restraints, opportunities, threats, and industry-specific challenges).

Solution Provided:

1. Methodology Adopted by MnM :

MnM conducted multi-level, qualitative & quantitative s....

1. Methodology Adopted by MnM :

MnM conducted multi-level, qualitative & quantitative study with both top-down and bottom-up approaches using a sample of industry professionals. Key parameters influencing the market were identified and their trends were studied to get the market numbers.  At every level the estimates were verified by primary interviews with industry experts (both from demand and supply side). MnM analyzed current & forecast quantitative market information, and developed deep-dive qualitative insights of industry trends & dynamics across each target region.

2. Actual Solution Provided:

   • Analysis of various macro and micro factors impacting market growth
   • Estimation of historical, current, and forecast market size for global blood gas analyzer market in terms of value as well as volume
   • Identified companies that offers blood gas analyzers products
   • Market sizing and forecasting for key players of blood gas analyzers – by brand and installed base
   • Information on key players in terms of geographic presence, product portfolio, recent developments, and business model
   • Competitive landscape of companies
   • Market share analysis of major competitors at regional level (U.S., Global)
   • Detailed analysis of need-gap incurred in this market

Value Delivered:

The study assisted client in knowing its competitors and aid in taking necessary steps to customize its product offerings and also, to formulate optimum strategy to grab market opportunity in high growth regions.

less...
Request Customization
 more...
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth In-Vitro Diagnostics Markets on KnowledgeStore
Request Demo